menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Zoetis to Participate in Upcoming Investor Conferences

    BUSINESSWIRE

    US gives conditional nod to Zoetis` bird flu vaccine for poultry

    REUTERS

    Zoetis Announces Label Update for Librela, a Treat Osteoarthritis

    BUSINESSWIRE

    Zoetis To Host Webcast On Q4 And Full Year 2024 Results

    BUSINESSWIRE

    Zoetis Announces 16% Dividend Increase For 1Q 2025

    BUSINESSWIRE

    Zoetis to Attend Piper Sandler 36th Annual Healthcare Conference

    BUSINESSWIRE

    Zoetis Appoints Jamie Brannan as Chief Commercial Officer

    BUSINESSWIRE

    Zoetis Declares Fourth Quarter 2024 Dividend

    BUSINESSWIRE

    Zoetis To Host Webcast On Third Quarter 2024 Results

    BUSINESSWIRE

    US animal health major Zoetis expands GCC in Hyderabad

    ECONOMICTIMES

    Zoetis To Participate In Morgan Stanley Global Healthcare Conference

    BUSINESSWIRE

    Zoetis lifts 2024 results forecasts on strong demand for pet treatments

    REUTERS

    Zoetis To Host Q2 2024 Financial Results Webcast And Call

    BUSINESSWIRE

    Zoetis Declares Third Quarter 2024 Dividend

    BUSINESSWIRE

    Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)

    BUSINESSWIRE

    Zoetis Announces First Quarter 2024 Results

    BUSINESSWIRE

    Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health

    BUSINESSWIRE

    Zoetis to Host Webcast and Conference Call on First Q24 Financial Results

    BUSINESSWIRE

    Zoetis to Participate in the Barclays Global Healthcare Conference

    BUSINESSWIRE

    Zoetis to Participate in Bank of America Securities 2024 Animal Health Summit

    BUSINESSWIRE

    Blacksmith Medicines and Zoetis Announce Research Collaboration

    PR NEWSWIRE

    Zoetis Declares Second Quarter 2024 Dividend

    BUSINESSWIRE

    Zoetis to Host Conference on Fourth Quarter and Full Year 2023 Financial Results

    BUSINESSWIRE

    Zoetis Announces Third Quarter 2023 Results

    BUSINESSWIRE

    Zoetis to Participate in Morgan Stanley 21st Annual Global Healthcare Conference

    BUSINESSWIRE

    Zoetis Welcomes Officials to Celebrate New R&D Building in Durham, N.C.

    BUSINESSWIRE

    Zoetis Welcomes Officials to Open New State-of-the-Art Facility in Lincoln

    BUSINESSWIRE

    Zoetis Announces Second Quarter 2023 Results

    BUSINESSWIRE

    Zoetis Announces Appointment of Ester Banque as President

    BUSINESSWIRE

    Zoetis to Host Webcast and Conference Call on Second Quarter 2023 FYR

    BUSINESSWIRE

    Zoetis Named One of the World’s Most Ethical Companies by Ethisphere

    BUSINESSWIRE

    Zoetis to Participate in the TD Cowen Health Care Conference

    BUSINESSWIRE

    Zoetis Reports Fourth Quarter and Full Year 2022 Results

    BUSINESSWIRE

    Zoetis Declares Second Quarter 2023 Dividend

    BUSINESSWIRE

    Why Zoetis Stock Lost 40% in 2022

    FOOL

    EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool

    PR NEWSWIRE

    Zoetis to Host Webcast on Fourth Quarter and Full Year 2022 Financial Results

    PRESS RELEASE

    Zoetis to Participate in the 41st Annual J.P. Morgan Healthcare Conference

    PRESS RELEASE

    Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase

    BUSINESSWIRE

    Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference

    BUSINESSWIRE

    Zoetis jumps 11% this week

    YAHOO

    Zoetis Announces Pricing of $1.35 Billion of Senior Notes

    PRESS RELEASE

    Zoetis Announces Third Quarter 2022 Results

    BUSINESSWIRE

    3 Dividend Stocks That Could Soar 51% to 58%, According to Wall Street

    FOOL

    Zoetis Declares Fourth Quarter 2022 Dividend

    BUSINESSWIRE

    Zoetis Named to Fortune’s 2022 Change the World List

    BUSINESSWIRE

    A Rising Dollar May Mean Lower Zoetis Shares

    SEEKING ALPHA

    Zoetis Announces the Completion of its Acquisition of Jurox

    BUSINESSWIRE

    Zoetis to Host Webcast and Conference on Third Quarter 2022 Financial Results

    BUSINESSWIRE

    Zoetis to Participate in the Morgan Stanley Global Healthcare Conference

    BUSINESSWIRE

    Zoetis Announces Second Quarter 2022 Results

    BUSINESSWIRE

    Zoetis Appoints Vanessa Broadhurst to its Board of Directors

    BUSINESSWIRE

    Zoetis to Host Webcast and Conference Call on Second Quarter 2022

    BUSINESSWIRE

    Zoetis to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

    BUSINESSWIRE

    Zoetis Announces First Quarter 2022 Results

    BUSINESSWIRE

    Zoetis to Host Webcast and Conference Call on Q1 2022 Financial Results

    BUSINESSWIRE

    Zoetis Announces FDA Approval of Solensia to Control Osteoarthritis Pain in Cats

    BUSINESSWIRE

    Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program

    BUSINESSWIRE

    Zoetis Announces Second Quarter 2021 Results

    BUSINESSWIRE

    Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.